Inventor · disambiguated record
Andrew Goodearl
Also filed as: GOODEARL ANDREW · GOODEARL ANDREW D · GOODEARL ANDREW D J · GOODEARL ANDREW DAVID
24 granted patents·6 pending applications·467 citations·filing 1993–2015
96Inventor score
Files withLUDWIG INST CANCER RES13MILLENNIUM PHARM INC7CAMBRIDGE NEUROSCIENCE INC4ACORDA THERAPEUTICS INC3ABBVIE INC1
Top patents by PatentIndex Score
30 records- 0196US5530109ADNA encoding glial mitogenic factorsLUDWIG INST CANCER RES·Filed 1993·Granted Jun 25, 1996·136 cites·12 claims
- 0294US5716930AGlial growth factorsLUDWIG INST CANCER RES·Filed 1994·Granted Feb 10, 1998·109 cites·4 claims
- 0383US5594114ASchwann cell mitogenic factor, its preparation and useLUDWIG INST CANCER RES·Filed 1994·Granted Jan 14, 1997·61 cites·1 claims
- 0479US6573057B2Methods of using transporter-like molecules to treat pain and pain-related disordersMILLENNIUM PHARM INC·Filed 2001·Granted Jun 3, 2003·5 cites·12 claims
- 0579US6093545AMethods for detecting nucleic acid molecules encoding a member of the muscarinic family of receptorsMILLENNIUM PHARM INC·Filed 1998·Granted Jul 25, 2000·41 cites·17 claims
- 0678US6313271B1OCT-3 polypeptidesMILLENNIUM PHARM INC·Filed 2000·Granted Nov 6, 2001·3 cites·9 claims
- 0778US6232286B1Methods of stimulating mitogenesis in glial cells using glial mitogenic factorsCAMBRIDGE NEUROSCIENCE RES·Filed 1995·Granted May 15, 2001·27 cites·8 claims
- 0876US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 0972US7319019B1Glial mitogenic factors lacking an N-terminal signal sequenceACORDA THERAPEUTICS INC·Filed 1996·Granted Jan 15, 2008·18 cites·9 claims
- 1067US7541338B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 2, 2009·0 cites·14 claims
- 1165US5602096AMethod of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesisLUDWIG INST CANCER RES·Filed 1995·Granted Feb 11, 1997·11 cites·2 claims
- 1263US6147190AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 14, 2000·11 cites·22 claims
- 1361US5854220AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Dec 29, 1998·9 cites·3 claims
- 1460US2003159162A1Methods of using transporter-like molecules to treat pain and pain-related disordersMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1557US7135456B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1995·Granted Nov 14, 2006·8 cites·18 claims
- 1657US6277565B1OCT-3 gene encoding transporter-like moleculesMILLENNIUM PHARM INC·Filed 1997·Granted Aug 21, 2001·6 cites·23 claims
- 1754US2005106666A1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 1853US2004209287A1OCT1p, a protein having homology to the organic and sugar transporter family of proteins, and uses thereofMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1951US2002137142A1Tango-73 nucleic acidsMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2048US7285531B1Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factorLUDWIG INST CANCER RES·Filed 1995·Granted Oct 23, 2007·7 cites·6 claims
- 2141US6972280B2Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Dec 6, 2005·5 cites·7 claims
- 2240US7192915B1Methods for treating multiple sclerosis with GGF-related polypeptidesLUDWIG INST CANCER RES·Filed 1996·Granted Mar 20, 2007·1 cites·3 claims
- 2339US6194377B1Methods for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Feb 27, 2001·1 cites·22 claims
- 2439US5621081AGlial mitogenic factorsLUDWIG INST CANCER RES·Filed 1995·Granted Apr 15, 1997·1 cites·4 claims
- 2538US7094749B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Aug 22, 2006·4 cites·5 claims
- 2638US5606032AProcess for preparing glial mitogenic factorsLUDWIG INST CANCER RES·Filed 1995·Granted Feb 25, 1997·1 cites·12 claims
- 2738US2014212423A1Blood-brain barrier penetrating dual specific binding proteinsHANZATIAN DENISE KARAOGLU·Filed 2013·Application pending·0 cites
- 2835US6204241B1Method for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Mar 20, 2001·1 cites·21 claims
- 2934US5792849AGlial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1995·Granted Aug 11, 1998·0 cites·62 claims
- 3029US2016002343A1Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseasesABBVIE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Goodearl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →